《大行報告》里昂上調華虹(01347.HK)目標價至85元 評級「買入」
里昂發表報告指,華虹半導體(01347.HK)去年第四季收入為2.8億美元,毛利率則為26%,表現均優於集團指引及市場預期,主要是受惠於無錫廠房有良好進步,符合該行早前預期。
該行表示,華虹半導體將在今明兩年加快無錫廠房的擴展,使其成為唯一擁有具規模新增產能的專業廠房,以捕捉嚴重供應緊張下的強勁需求。
里昂上調華虹股份目標價,由52元大升至85元,維持「買入」評級,並調升集團今明兩年每股盈利預測分別19%及21%。該行估計華虹2020至2022年的收入可倍翻,明顯跑贏晶圓代工行業平均數。另外由於8吋晶圓價格上漲,預期集團的盈利亦會有強勁反彈,其股本回報率料由去年的4%,增至明年的12%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.